Related and Nonrelated Parties [Axis] Total Current Assets Total Assets Total Current Liabilities Total long-term liabilities Total Liabilities Total stockholders’ deficit Balance Balance as of March 31, 2025 Total Liabilities and Stockholders’ Deficit Product and Service [Axis] Gross Profit Total operating expenses (Loss) Income from operations Total other expenses Net (loss) income before income taxes Comprehensive (loss) income Balance (in Shares) Balance as of March 31, 2025 (in Shares) Equity Components [Axis] Net cash used in operating activities Operating activities amount Net cash (used in) provided by financing activities Cash and restricted cash, beginning of year Cash and restricted cash, end of period Total cash and restricted cash shown in the statement of cash flows Nature of the Business [Abstract] Summary of Significant Accounting Policies [Abstract] Schedule of Reconciliation of Cash and Restricted Cash [Abstract] Schedule of Contract Liabilities [Abstract] Beginning balance Ending balance Contract liabilities Schedule of Reconciliation of the Number of Shares used in the Calculation of Basic and Diluted (loss) Earnings Per Share [Abstract] Antidilutive Securities [Axis] Intra-Entity Foreign Currency Balance by Description [Axis] Income Taxes [Abstract] Schedule of Differences between U.S. Statutory Federal Rate Estimated Effective Tax Rate [Abstract] Income tax expense Income tax benefit Income tax benefit Total provision for income taxes, percentage Schedule of Deferred Tax Assets [Abstract] Schedule of Income Tax Provision (Benefit) [Abstract] Total Current Total Deferred Schedule of Loss Income Before Taxes for Domestic and Foreign Jurisdictions [Abstract] Schedule of Income Tax Expense[Abstract] Current Accounts Receivable [Abstract] Schedule of Accounts Receivable, Net of Allowances for Doubtful Accounts [Abstract] Total accounts receivable, net Prepaid Expenses [Abstract] Total Prepaid expenses (including related party amount of $652,270 and $110,803, respectively) Concentration of Credit Risk [Abstract] Inventory [Abstract] Schedule of Carrying Value of Inventory [Abstract] Total inventory Inventory, net Intangible Assets [Abstract] Schedule of Intangible Assets [Abstract] Intangible assets, net Intangible assets, net Long-lived assets (net) Schedule of Estimated Aggregate Amortization Expense [Abstract] Related Party Transactions [Abstract] Accounts Payable and Accrued Liabilities [Abstract] Schedule of Accounts Payable and Accrued Liabilities [Abstract] Total Accounts payable and accrued liabilities (including payable to shareholder of $193,641 and $197,512, respectively) Notes Payable [Abstract] Short-Term Debt, Type [Axis] Schedule of Future Payments [Abstract] Stockholders’ Deficit [Abstract] Commitments and Contingencies [Abstract] Stock Options and Warrants [Abstract] Schedule of Options Outstanding, Option Exercisability and Related Prices for Shares [Abstract] Schedule of Stock Option Activity [Abstract] Options, Outstanding beginning Options, Outstanding ending Weighted Average Exercise Price, Outstanding beginning Weighted Average Exercise Price, Outstanding ending Class of Warrant or Right [Axis] Exercise Price Range [Axis] Statistical Measurement [Axis] Warrants, Outstanding beginning balance Warrants, Outstanding ending balance Weighted Average Exercise Price, Outstanding beginning balance Weighted Average Exercise Price, Outstanding ending balance Segments [Abstract] Geographical [Axis] Segments [Axis] Subsequent Events [Abstract] Assets Current Assets Cash and cash equivalents Restricted cash Accounts receivable, net Prepaid expenses related party Prepaid balance Liabilities and Stockholders’ Deficit Current Liabilities: Payable to shareholder Income taxes payable Short term loans payable, net of debt discount, related party Current portion of notes payable, net of debt discount Long-term Liabilities: Notes payable, net of debt discount Commitments and contingencies Stockholders’ Deficit: Common stock, $0.00001 par value; 300,000,000 shares authorized; 11,483,926 shares issued; 11,303,853 outstanding Common stock par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares authorized Common stock, shares issued (in Shares) Shares of common stock (in Shares) Common stock, shares issued Common stock, shares outstanding (in Shares) Common stock outstanding (in Shares) Common stock, shares outstanding Additional paid in capital Common stock to be issued Accumulated other comprehensive loss Accumulated deficit Treasury stock cost (in Shares) Revenue Total Revenue Revenue Revenue by major sales Cost of Sales Operating expenses Selling and marketing General and administrative Depreciation and amortization Other (income) expenses Interest expense Remeasurement loss on translation of foreign subsidiary Net (loss) income after tax Net (loss) income Net (loss) income after tax (in Dollars) Net (loss) income per share – basic (in Dollars per share) Basic (in Dollars per share) Penny per share (in Dollars per share) Net (loss) income per share - diluted (in Dollars per share) Diluted (in Dollars per share) Weighted average common shares outstanding Basic (in Shares) Diluted (in Shares) Dilutive potential common shares Comprehensive (loss) income: Foreign currency translation adjustment Foreign currency translation income (loss) Issuance of common stock for loan financing Issuance of common stock for loan financing (in Shares) Shares issued for services (in Shares) Fair value of vested stock options Common stock to be issued for accounts receivable advance financing Cash Flows from Operating Activities Adjustments to reconcile net (loss) income to net cash used in operating activities: Amortization of debt discount and debt issuance cost Stock based compensation Changes in operating assets and liabilities: Income taxes payable Contract liabilities Accounts payable and accrued liabilities Accounts payable, related party Cash Flows from Investing Activities Cash Flows from Financing Activities Advances from related party Proceeds from notes payable Effect of exchange rate on cash, cash equivalents and restricted cash Net decrease in cash, cash equivalents and restricted cash Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Supplemental Disclosure of Noncash Investing and Financing Activities: Issuance of common stock for accounts receivable advance financing Loan financing fees, accrued Capitalized interest on senior debt Common stock to be issued for accounts receivable advance financing Less: Treasury stock (180,073 shares) at cost Interest income Foreign currency transaction loss (gain) Remeasurement loss (gain) on translation of foreign subsidiary Accounts receivable Other receivables Loan receivable, related party Inventory Prepaid expenses Prepaid expense, related party Repayment of notes payable, related party Payment of loan financing fees Repayment of notes payable Related Party Related Party [Member] Product Sales License Revenue License [Member] Common stock Additional Paid in Capital Accumulated Other Comprehensive Income (Loss) Treasury stock Accumulated Deficit Common stock to be issued Nature of the Business Summary of Significant Accounting Policies Schedule of Reconciliation of Cash and Restricted Cash Cash Schedule of Contract Liabilities Additions Recognized as revenue Schedule of Reconciliation of the Number of Shares used in the Calculation of Basic and Diluted (loss) Earnings Per Share Weighted average common shares outstanding Incremental shares from the assumed exercise of dilutive stock options